Unknown OBSERVATIONAL NCT00145262

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Therapeutic Angiogenesis Using Cell Transplantation (TACT) Study at Nagoya

Sponsor: Nagoya University

Conditions Arteriosclerosis Obliterans Buerger Disease

Interventions Autologous Bone Marrow Mononuclear Cell Implantation

Updated 6 times since 2017 Last updated: Dec 29, 2005 Started: Aug 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00145262, this observational or N/A phase trial focuses on Arteriosclerosis Obliterans and Buerger Disease and remains ongoing. Sponsored by Nagoya University, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: PHASE2 → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status PHASE2

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nagoya University

Data source: Nagoya University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nagoya, Japan